Clinical Trial Update: Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing venetoclax plus decitabine (DEC3-VEN) versus venetoclax plus azacitidine (VIALE-A) in elderly or unfit, newly diagnosed acute myeloid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Decitabine (Decitabine)
• Venetoclax (venetoclax)

Snippet

Sponsor: The Second Affiliated Hospital of Kunming Medical University | Conditions: Elderly AML Patients, Unfit, New-diagnosis AML | Phase 3 | Status: UNKNOWN